• Creating in-depth, scientifically-sound target product profiles and development strategies to effectively manage portfolios
  • Conducting in-depth Key Opinion Leader (KOL) interviews & Scientific Advisory Board (SAB) meetings
  • Identifying specific go/no-go hurdles to enable informed decisions and establish objective criteria for continuing or ending a
    project
We Provide As-needed, Timely and Comprehensive Support to Biopharmaceutical Executives
and Development Teams Engaged in New Product Planning

Experts in Virtual Drug Development & Team Mentoring
This website Copyright 2007 De Young & Hayden, LLC.
.

"Larry and Brad worked with us on due diligence projects including product evaluation. They provided the kind of information we
needed to support our internal decision making process.  Due to Larry’s & Brad’s scientific, biopharmaceutical and therapeutic
area expertise, this team required minimum briefing and guidance which allowed us to meet challenging project deadlines.
Furthermore, we were also impressed with the top-level Key Opinion Leaders that they were able to bring to our projects."

"In summary, premium service at very reasonable cost."

Christian Pangratz, Director/Program Leader, NEKTAR THERAPEUTICS
De Young & Hayden, LLC (DYH)
  • Producing high-level regulatory documentation and professional publications
  • Strengthening internal and external communication to influence decision makers and expedite approvals
  • Supporting clients' scientific and marketing messages from preclinical planning through NDA filing and marketing
  • Training key personnel
Knowledge
Communication